CLINICAL_TRIALS
trial_result
· 2021-12-10
Clinical Trial Update: Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD) [Phase 3]
Summary
Phase 3 study assessing safety and tolerability in adults with growth hormone deficiency has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Growth Hormone Deficiency | Phase 3 | Status: TERMINATED